TherapeuticsMD, Inc. (TXMD)
1.75
-0.09
(-4.89%)
USD |
NASDAQ |
Dec 12, 16:00
1.76
+0.01
(+0.57%)
After-Hours: 20:00
TherapeuticsMD Shareholders Equity (Quarterly): 27.44M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 9.619B |
| Eli Lilly & Co. | 23.79B |
| Pfizer Inc. | 92.80B |
| AbbVie, Inc. | -2.642B |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 38.67M |
| Total Liabilities (Quarterly) | 11.23M |
| Debt to Equity Ratio | 0.2362 |
| Current Ratio | 2.461 |
| Net Debt Paydown Yield | 1.78% |